Personal information

Websites & social links

http://haema-cbf.charite.de/forschung/wissenschaftliche_arbeitsgruppen/ag_baldus/

Countries

Germany

Activities

Collapse all

Works (3)

Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia

Blood Advances
2025-03-25 | Journal article
DOI: 10.1182/bloodadvances.2024013304
Contributors: Leo Ruhnke; Marius Bill; Sven Zukunft; Jan-Niklas Eckardt; Silvia Schäfer; Sebastian Stasik; Maher Hanoun; Thomas Schroeder; Lars Fransecky; Björn Steffen et al.
Source: check_circle
Crossref

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Blood Advances
2022-08-23 | Journal article
DOI: 10.1182/bloodadvances.2022007776
Contributors: Kai Rejeski; Andreas Burchert; Gloria Iacoboni; Pierre Sesques; Lars Fransecky; Veit Bücklein; Corinna Trenker; Rafael Hernani; Ralph Naumann; Jonas Schäfer et al.
Source: check_circle
Crossref

Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL

Journal of Hematology & Oncology
2016-12 | Journal article
DOI: 10.1186/s13045-016-0324-8
Contributors: L. Fransecky; M. Neumann; S. Heesch; C. Schlee; J. Ortiz-Tanchez; S. Heller; M. Mossner; S. Schwartz; L. H. Mochmann; K. Isaakidis et al.
Source: check_circle
Crossref

Peer review (6 reviews for 2 publications/grants)

Review activity for Annals of hematology. (4)
Review activity for European journal of cancer. (2)
How many people are using ORCID?